Thus, in contrast to E2a:PBX leukaemia, Eμ-RET pre-B cell ALL did not relapse following CD19 CAR via lineage switch suggesting that the occurrence of this resistance mechanism may depend on the genetic driver. This evidence concerns the gene CD19 and leukemia.